Diaziquone
Alternative Names: AZQ; CI 904; NSC 182986Latest Information Update: 30 Aug 2002
At a glance
- Originator National Institutes of Health (USA); Nonindustrial source
- Developer National Institutes of Health (USA)
- Class Aziridines; Benzoquinones; Cytostatics; Small molecules
- Mechanism of Action Alkylating agents; DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported CNS cancer